HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its subsidiary, BI Sky Global (BI),...
Read More Details
Finally We wish PressBee provided you with enough information of ( Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone )
Also on site :
- 21-year-old Baloch student becomes another victim of extrajudicial killing by Pakistani forces
- Gold miners killed in pit collapse in war-torn Sudan
- This Week on 'Beyond the Gates' Welcome to Fairmont Crest